Medical Weight Loss
Published
August 8, 2026
14
3400
GLP-1 and Your Heart: The Trial Data Explained — A Complete Patient Guide
GLP‑1 medications reduce inflammation, improve endothelial function, lower blood pressure, and significantly reduce cardiovascular events. This guide explains the trial data, who benefits most, and what patients should know.

Quick Answer
GLP‑1 medications like semaglutide and liraglutide reduce major cardiovascular events by 20–26% in high‑risk patients. Benefits occur even in people without diabetes, driven by reduced inflammation, improved vascular health, and weight loss.
Watch Related Video
Article
Published Date:
2026-09-12 21:33
Word Count:
3400
Estimated Read Time:
14
Obesity By The Numbers
Key statistics that highlight the growing impact of obesity.
GLP‑1 medications reduce inflammation, improve endothelial function, lower blood pressure, reduce visceral fat, and improve metabolic flexibility — all of which protect the heart.
Medical Topics Covered
This article covers the following medical topics and related areas.


Nestor de la Cruz-Muñoz, MD, FACS, DABOM
About the Author
Nestor de la Cruz‑Muñoz, MD, FACS, DABOM
Dr. Nestor de la Cruz‑Muñoz is a nationally recognized bariatric, metabolic, and foregut surgeon with more than 20 years of experience treating complex obesity‑related and gastrointestinal conditions. He serves as the Medical Director of Bariatric and Metabolic Surgery at HCA Florida Mercy Hospital and has held academic appointments as a Professor of Surgery at a major university‑based medical center.
Dr. de la Cruz‑Muñoz specializes in advanced minimally invasive and robotic surgery, metabolic disease management, and comprehensive long‑term patient care. His work integrates clinical expertise, academic leadership, and a commitment to evidence‑based medicine. He has trained surgeons across the country, contributed to national guidelines, and is widely regarded for his outcomes, innovation, and patient‑centered approach.
Patients choose Dr. de la Cruz‑Muñoz for his combination of surgical excellence, metabolic expertise, and lifelong dedication to improving patient health through compassionate, high‑quality care.
Dr. de la Cruz‑Muñoz specializes in advanced minimally invasive and robotic surgery, metabolic disease management, and comprehensive long‑term patient care. His work integrates clinical expertise, academic leadership, and a commitment to evidence‑based medicine. He has trained surgeons across the country, contributed to national guidelines, and is widely regarded for his outcomes, innovation, and patient‑centered approach.
Patients choose Dr. de la Cruz‑Muñoz for his combination of surgical excellence, metabolic expertise, and lifelong dedication to improving patient health through compassionate, high‑quality care.











